Press Release: AMCP comments in joint statement on the Administration’s latest initiative to modernize substance use disorder (SUD) treatment privacy law and enhance coordinated care and safety.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in response to its proposed rule, “Medicare Program; Secure Electronic Prior Authorization for Medicare Part D [CMS-4819-P]” published in the Federal Register on June 19, 2019.
The Academy of Managed Care Pharmacy (AMCP) thanks the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in response to the notice titled “Advance Summary of Methodological Changes for Calendar Year (CY) 2020 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2020 Call Letter [CMS-2018-0154]” released on January 30, 2019.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in response to its, “Request for Information; Reducing Administrative Burden To Put Patients Over Paperwork [CMS-6082-NC],” published in the Federal Register on June 11, 2019.
July 2019 News & Views: Partnership Forum Develops Recommendations to Improve PA Process; Nominations Are Now Open for Positions on AMCP Board of Directors; AMCP, HOPA Cohost Forum on Value of Cancer Care; JMCP is Featured in Alliance for Aging Research Event
On July 23, Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-OR) released the Chairman’s Mark of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, bipartisan legislation to reduce health care costs. AMCP will continue to engage with staff on the Finance committee on these provisions as we have with Members and staff on the Senate Health, Education, Labor, and Pensions (HELP) Committee.
AMCP CEO Blog: We live in an interconnected world where the marketplace for all things is global. But we must also make sure the global system works for the benefit of the patients we serve. That includes taking steps to ensure the long-term stability and integrity of our critical pharmaceutical supply chain.